Newsmax Health Multiple sclerosis makes people vulnerable to more severe cases of COVID-19, but a new study finds that getting the COVID vaccine won’t trigger a relapse of MS symptoms. “People with MS have an increased risk of severe COVID infection due to their level of motor disability or exposure to treatments that suppress their […]
Pooja Reddy • Pradeep Kumar Devarakonda • Gregory Gotlieb • Pedro Moreno: June 21, 2024,DOI: 10.7759/cureus.62836 Abstract The COVID-19 pandemic has resulted in substantial lifestyle changes with significant implications for nutritional health. Factors such as movement restrictions and disruptions in food supply chains led to the restricted availability of primary sources of essential micronutrients. To highlight this, we present the case of an […]
Authored by Alex Wu via The Epoch Times, The Chinese Center for Disease Control and Prevention (CDC) reported that new COVID-19 infections in the country of origin have increased to nearly 20 percent in the past few weeks, as two new Omicron subvariants spread across the country. But while increases to China’s official COVID-19 test […]
Last updated April 26, 2024, News & Magazine NewsroomHSC NewsUSC Health, Interviewed by Eric Weintraub, Additional Expertise Contributions by Dr. Brian Toy Much continues to remain unknown about the constantly evolving coronavirus disease 2019 (COVID-19). However, more information has become available in the past 1.5 years regarding COVID-19’s effects on one of the most sensitive parts […]
By Maiya Focht, A new study has added fuel to concerns that America could face a surge in dementias in coming years and decades due to COVID. The research found that nearly two-thirds of people over 65 who were hospitalized with the virus went on to suffer cognitive decline, which can be a precursor for dementia, weeks […]
Zoe O Demko, Tong Yu, Sarika K Mullapudi, et. al., Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae027, https://doi.org/10.1093/ofid/ofae027 Abstract Background Few longitudinal studies available characterize long COVID outcomes out to 24 months, especially in people with nonsevere acute coronavirus disease 2019 (COVID-19). This study sought to prospectively characterize incidence and duration of long COVID symptoms […]
Yixin Huang, Tongyun Wang, Lijie Zhong, et. al., Nature Abstract Coronaviruses remodel the intracellular host membranes during replication, forming double-membrane vesicles (DMVs) to accommodate viral RNA synthesis and modifications1,2. SARS-CoV-2 non-structural protein 3 (nsp3) and nsp4 are the minimal viral components required to induce DMV formation and to form a double-membrane-spanning pore, essential for the transport of newly […]
Yuying Ma, Lijun Zhang, Rui Wei, et. al, BMC Medicine volume 22, Article number: 14 (2024) Cite this article Abstract Background In the post-pandemic era, a wide range of COVID-19 sequelae is of growing health concern. However, the risks of digestive diseases in long COVID have not been comprehensively understood. To investigate the long-term risk of digestive diseases among COVID patients. Methods In this […]
Volume 10, pages 169–180, (2024), Elliott K Lee & R. Robert Auger Abstract Purpose of Review Post Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2), also known as PASC, and frequently referred to as “long-COVID,” is estimated to afflict over 65 million people worldwide. Sleep disturbances and fatigue are some of the most frequently cited PASC symptoms, and […]
Roxana Gheorghita1,2Iuliana Soldanescu3Andrei Lobiuc2 , et. al., Front. Immunol., 03 March 2024, Sec. Viral Immunology, Volume 15 – 2024 | https://doi.org/10.3389/fimmu.2024.1344086 The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has been defined as the greatest global health and socioeconomic crisis of modern times. While most people recover after being infected with the virus, a significant […]